Smoothing the mosaic subclinical melanoderma by calcipotriol

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 5, 2007, Pages 657-661

  Pierard Franchimont C ^a   Paquet, P ^a   Quatresooz, P ^a   Piérard, Gerald E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Hair follicle; Melanin; Melanoderma; ULEV method; Vitamin D3

Indexed keywords

CALCIPOTRIOL; LANOLIN ALCOHOL; MELANIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; EPIDERMIS; FOLLOW UP; HUMAN; HUMIDIFIER; MALE; MELANOCYTE; MOSAIC SUBCLINICAL MELANODERMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; SKIN PIGMENTATION; VIDEORECORDING;

ADMINISTRATION, TOPICAL; CALCITRIOL; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MELANOSIS; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET RAYS;

EID: 34250349072     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.02048.x     Document Type: Article

References (30)

1. Hermanns JF, Petit L, Piérard-Franchimont C, Cauwenbergh G, Piérard GE. Unraveling the patterns of subclinical pheomelanin-enriched facial hyperpigmentation: Effect of depigmenting agents. Dermatology 2000; 202: 118-122.
2. Petit L, Piérard-Franchimont C, Saint Léger D, Loussouarn G, Piérard GE. Subclinical speckled perifollicular melanosis of the scalp. Eur J Dermatol 2002; 12: 565-568.
3. Hermanns JF, Petit L, Piérard-Franchimont C, Paquet P, Piérard GE. Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology 2002; 204: 281-286.
4. Petit L, Fogouang L, Uhoda I et al. Regional variability in mottled photo-induced melanoderma in the elderly. Exp Gerontol 2003; 38: 327-331.
5. Quatresooz P, Petit L, Uhoda I, Piérard-Franchimont C, Piérard GE. Mosaic subclinical melanoderma. An Achilles heel for UV-related epidermal cancerogenesis? Int J Oncol 2004; 25: 763-768.
6. Uhoda E, Piérard-Franchimont C, Petit L, Piérard GE. The conundrum of skin pores in dermocosmetology. Dermatology 2005; 210: 3-7.
7. Xhauflaire-Uhoda E, Hermanns JF, Piérard-Franchimont C, Piérard GE. Highlighting the rim of perifollicular epidermal unit. Eur J Dermatol 2006; 16: 225-229.
8. 3 analogues. Dermatol Ther 1999; 11: 20-31.
9. -1 ointment on chronic plaque psorasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003; 148: 326-333.
10. 3 derivatives. Dermatology 2003; 206: 366-369.
11. 3 and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology 1981; 108: 1083-1086.
12. 3 metabolites. Cancer Res 1983; 43: 4443-4447.
13. 3. Cancer Res 1987; 47: 21-25.
14. 3 and α-melanocyte stimulating hormone, and beta-estradiol. J Invest Dermatol 1988; 91: 593-598.
15. 3 in human malignant melanoma cell lines. J Surg Res 1996; 61: 127-133.
16. 3 in primary human melanocytes. Melanoma Res 2003; 13: 339-347.
17. Virador VM, Muller J, Wu X et al. Influence of α-melanocyte-stimulating hormone and ultraviolet radiation on the transfer of melanosomes to keratinocytes. FASEB J 2002; 16: 105-107.
18. Kvam E, Tyrrel RM. The role of melanin in the induction of oxidative DNA base damage by ultraviolet A irradiation of DNA or melanoma cells. J Invest Dermatol 1999; 113: 209-213.
19. Bykov VJ, Marcusson JA, Hemminki K. Protective effects of tanning on cutaneous DNA damage in situ. Dermatology 2001; 202: 22-26.
20. 3 and its analogues. Cell Death Differ 1998; 5: 946-952.
21. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005; 16: 83-95.
22. Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98: 451-459.
23. Baker AR, McDonnell DP, Hughes M et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988; 85: 3294-3298.
24. Jimenez-Lara AM, Aranda A. Interaction of vitamin D and retinoid receptors on regulation of gene expression. Horm Res 2000; 54: 301-305.
25. Boehm N, Samama B, Cribier B, Rochette Egly C. Retinoic-acid receptor β expression in melanocytes. Eur J Dermatol 2004; 14: 19-23.
26. Hutchinson PE, Osborne JE, Lear JT et al. Vitamin D receptor polymorphisms are associated with altered prognosis in patients with malignant melanoma. Clin Cancer Res 2000; 6: 498-504.
27. Haddad MM, Xu W, Medrano EE. Aging in epidermal melanocytes: Cell cycle genes and melanins. J Investig Dermatol Symp Proc 1998; 3: 36-40.
28. Takema Y, Yorimoto Y, Ohsu H, Osanai O, Kawai M. Age-related discontinuous changes in the in vivo fluorescence of human facial skin. J Dermatol Sci 1997; 15: 55-58.
29. Leffell DJ, Stetz ML, Milstone LM, Deckelbaum LI. In vivo fluorescence of human skin: A potential marker of photoaging. Arch Dermatol 1999; 124: 1514-1518.
30. Fetil E, Ilknur T, Altiner A et al. Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. J Dermatol 2005; 32: 868-874.